Lv3
389 积分 2021-11-08 加入
Tumor Lysis Syndrome
13小时前
已关闭
Tumor Lysis Syndrome
18小时前
已完结
Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasms
1天前
已完结
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial
16天前
已完结
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
16天前
已关闭
Initial results of a multicenter phase 2 study of venetoclax in combination with R‐CHOP (VR‐CHOP) for patients with Richter Syndrome
16天前
已完结
《生活方式干预治疗和缓解成人2型糖尿病和糖尿病前期的临床实践指南（2025）》：要点与解读
18天前
已完结
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE
28天前
已完结
Navigating diagnostic shifts: A comparative review of the WHO 5th edition and ICC 2022 classifications of myeloid neoplasms
1个月前
已完结
Distinctive Molecular Risk Factors Between MDS and MDS / AML Defined by ICC
1个月前
已完结
皖公网安备34019202002308
